Industries ranking
at least 5 stocks per industry
| Name | BPR | Stocks | ADR | Price Change | 20D $Vol | 5D $Vol | $Vol Change | Market Cap. | Price to 3D High | Price to 20D High | Price to 50D High | Price to 200D High |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers - Specialty & Generic | 59 | 79 | 8.25% | Decreased by -0.11% | 2.04 B | 1.78 B | Decreased by -12.77% | $283.43 B | 93.15% | 77.34% | 70.83% | 58.85% |
| Healthcare Plans | 57 | 12 | 5.16% | Increased by +0.02% | 5.47 B | 4.37 B | Decreased by -20.08% | $865.14 B | 93.42% | 86.32% | 81.33% | 72.59% |
| Biotechnology | 55 | 574 | 8.53% | Increased by +1.13% | 7.87 B | 8.38 B | Increased by +6.43% | $1.4 T | 93.47% | 75.27% | 65.03% | 53.84% |
| Medical Distribution | 55 | 8 | 2.36% | Increased by +0.71% | 818.76 M | 1 B | Increased by +22.32% | $148.38 B | 98.57% | 92.8% | 90% | 87.35% |
| Medical Care Facilities | 48 | 44 | 5.38% | Decreased by -0.9% | 1.12 B | 1.29 B | Increased by +15.66% | $197.22 B | 94.07% | 86.25% | 78.49% | 68.91% |
| Diagnostics & Research | 46 | 55 | 6.41% | Decreased by -0.04% | 3.9 B | 4.44 B | Increased by +13.95% | $746.8 B | 93.47% | 82.77% | 75.16% | 61.66% |
| Medical Devices | 45 | 123 | 6.84% | Increased by +0.46% | 5.19 B | 4.97 B | Decreased by -4.17% | $879.89 B | 94.24% | 81.79% | 72.38% | 57.61% |
| Health Information Services | 45 | 54 | 7.37% | Increased by +1.1% | 1.11 B | 877.83 M | Decreased by -21.2% | $137.31 B | 94.03% | 79.7% | 67.87% | 51.97% |
| Drug Manufacturers - General | 42 | 17 | 2.7% | Increased by +0.36% | 8.61 B | 9.65 B | Increased by +12.07% | $2.83 T | 97.32% | 90.47% | 85.79% | 77.39% |
| Medical Instruments & Supplies | 40 | 48 | 6.34% | Increased by +1.26% | 2.28 B | 2.14 B | Decreased by -6.27% | $428.99 B | 95.99% | 85.05% | 77.77% | 67.89% |
| Pharmaceutical Retailers | 32 | 5 | 8.25% | Increased by +1.05% | 249.43 M | 144.11 M | Decreased by -42.22% | $15.57 B | 94.37% | 68.38% | 59.75% | 40.02% |
Please note that not all stocks are included in these aggregate results. We exclude stocks with average dollar volume less than 100 000 and ones with extreme BPRs.